NCT07416409 2026-02-18Effectiveness, Safety, and Tolerability of Anti-HER2 Drugs as Targeted Therapy for Egyptian Patients With ERBB2-Positive Breast CancerDeraya UniversityCompleted80 enrolled
NCT02266173 2021-05-03Observational Study of Pertuzumab Safety in Participants With Breast CancerHoffmann-La RocheCompleted1,130 enrolled